Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Florian Krammer, Ron A. M. Fouchier, Maryna C. Eichelberger, et al.
mBio (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 256

Showing 1-25 of 256 citing articles:

The human antibody response to influenza A virus infection and vaccination
Florian Krammer
Nature reviews. Immunology (2019) Vol. 19, Iss. 6, pp. 383-397
Open Access | Times Cited: 641
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado, et al.
Molecular Therapy (2020) Vol. 28, Iss. 7, pp. 1569-1584
Open Access | Times Cited: 254
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon, et al.
Science (2019) Vol. 366, Iss. 6464, pp. 499-504
Open Access | Times Cited: 224
Co-evolution of immunity and seasonal influenza viruses
Alvin X. Han, Simon P. J. de Jong, Colin A. Russell
Nature Reviews Microbiology (2023) Vol. 21, Iss. 12, pp. 805-817
Closed Access | Times Cited: 53
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry
Corey Momont, Ha V. Dang, Fabrizia Zatta, et al.
Nature (2023) Vol. 618, Iss. 7965, pp. 590-597
Open Access | Times Cited: 52
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer, Peter Palese
Annual Review of Medicine (2019) Vol. 71, Iss. 1, pp. 315-327
Closed Access | Times Cited: 126
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, et al.
Leukemia (2020) Vol. 35, Iss. 1, pp. 31-44
Open Access | Times Cited: 118
Lessons From Influenza Pandemics of the Last 100 Years
Arnold S. Monto, Keiji Fukuda
Clinical Infectious Diseases (2019) Vol. 70, Iss. 5, pp. 951-957
Open Access | Times Cited: 110
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection
Maryna C. Eichelberger, Arnold S. Monto
The Journal of Infectious Diseases (2019) Vol. 219, Iss. Supplement_1, pp. S75-S80
Open Access | Times Cited: 94
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 91
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults
Hannah E. Maier, Raffael Nachbagauer, Guillermina Kuan, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 11, pp. 2290-2297
Open Access | Times Cited: 88
Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain
Florian Krammer, Peter Palese
The Journal of Infectious Diseases (2018) Vol. 219, Iss. Supplement_1, pp. S62-S67
Open Access | Times Cited: 86
Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies
Claudia P. Arevalo, Valerie Le Sage, Marcus J. Bolton, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 29, pp. 17221-17227
Open Access | Times Cited: 86
Protective Antibodies Against Influenza Proteins
Herbey Oswaldo Padilla-Quirarte, Delia Vanesa López-Guerrero, Lourdes Gutiérrez‐Xicoténcatl, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 83
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Rolle Rahikainen, Pramila Rijal, Tiong Kit Tan, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 1, pp. 321-330
Open Access | Times Cited: 73
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
Daniel Ellis, Julia Lederhofer, Oliver J. Acton, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids
Jenna M. Kastenschmidt, Suhas Sureshchandra, Aarti Jain, et al.
Immunity (2023) Vol. 56, Iss. 8, pp. 1910-1926.e7
Open Access | Times Cited: 43
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase
Ruipeng Lei, Wooseob Kim, Huibin Lv, et al.
Immunity (2023) Vol. 56, Iss. 11, pp. 2621-2634.e6
Closed Access | Times Cited: 25
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
Julia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 574-586.e7
Open Access | Times Cited: 15
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines
Caryn Myn Li Lim, Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 14
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains
Andrea N. Loes, Rosario Araceli L Tarabi, John Huddleston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
Anti-neuraminidase immunity in the combat against influenza
Xiaojian Zhang, Ted M. Ross
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 474-484
Open Access | Times Cited: 10
Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
Yongqiang Zhao, Shuangshuang Guo, Jia Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens
Seth J. Zost, Nicholas C. Wu, Scott E. Hensley, et al.
The Journal of Infectious Diseases (2018) Vol. 219, Iss. Supplement_1, pp. S38-S45
Open Access | Times Cited: 83
Influenza and Antibody-Dependent Cellular Cytotoxicity
Tarra Von Holle, M. Anthony Moody
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top